Wolfgang Baumgärtner Selected Research

Demyelinating Diseases (Demyelinating Disease)

1/2022	Astrocyte depletion alters extracellular matrix composition in the demyelinating phase of Theiler's murine encephalomyelitis.
11/2021	Double-edged effects of tamoxifen-in-oil-gavage on an infectious murine model for multiple sclerosis.
6/2019	Reactive Oxygen Species Are Key Mediators of Demyelination in Canine Distemper Leukoencephalitis but not in Theiler's Murine Encephalomyelitis.
4/2019	Delayed Astrogliosis Associated with Reduced M1 Microglia Activation in Matrix Metalloproteinase 12 Knockout Mice during Theiler's Murine Encephalomyelitis.
2/2019	Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
1/2018	Cytotoxic CD8+ T cell ablation enhances the capacity of regulatory T cells to delay viral elimination in Theiler's murine encephalomyelitis.
1/2017	Synaptophysin Is a Reliable Marker for Axonal Damage.
1/2016	Central Nervous System Demyelination and Remyelination is Independent from Systemic Cholesterol Level in Theiler's Murine Encephalomyelitis.
12/2015	Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
11/2015	Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang Baumgärtner Research Topics

Disease

51	Infections 05/2022 - 04/2002
31	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 04/2002
18	Inflammation (Inflammations) 05/2022 - 08/2007
14	Multiple Sclerosis 11/2021 - 08/2007
10	Neoplasms (Cancer) 06/2022 - 09/2006
10	Distemper (Canine Distemper) 06/2019 - 04/2002
9	Encephalomyelitis (Myeloencephalitis) 06/2019 - 08/2006
8	Virus Diseases (Viral Diseases) 12/2021 - 01/2012
7	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 11/2003
6	Histiocytic Sarcoma 05/2022 - 01/2016
6	Necrosis 01/2022 - 08/2006
6	Gliosis 01/2022 - 01/2012
5	Central Nervous System Diseases (CNS Diseases) 11/2021 - 11/2011
5	Spinal Cord Injuries (Spinal Cord Injury) 10/2014 - 05/2011
4	Persistent Infection 05/2022 - 10/2009
4	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2006
4	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2020 - 08/2005
4	Seizures (Absence Seizure) 01/2020 - 01/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2015 - 01/2013
3	Epilepsy (Aura) 01/2020 - 04/2013
3	Disease Progression 04/2019 - 09/2007
2	Meningitis 01/2022 - 01/2018
2	COVID-19 01/2022 - 01/2021
2	Arteritis 01/2022 - 01/2018
2	Edema (Dropsy) 01/2021 - 01/2021
2	Hyperplasia 01/2021 - 11/2020
2	Neuroinflammatory Diseases 10/2015 - 03/2014
2	Nervous System Trauma 01/2013 - 12/2007
2	Alzheimer Disease (Alzheimer's Disease) 08/2012 - 06/2008
2	Atrophy 06/2007 - 06/2005
1	Hypoxia (Hypoxemia) 03/2022
1	Communicable Diseases (Infectious Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 05/2022 - 08/2006
11	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2012
11	Messenger RNA (mRNA)IBA 01/2022 - 04/2002
10	Interleukin-10 (Interleukin 10)IBA 01/2022 - 04/2002
10	Matrix Metalloproteinases (MMPs)IBA 03/2021 - 11/2003
10	CuprizoneIBA 01/2017 - 12/2007
9	CytokinesIBA 07/2014 - 04/2002
6	AntigensIBA 01/2022 - 01/2013
6	Tissue Inhibitor of Metalloproteinase-1IBA 03/2021 - 10/2005
6	ParaffinIBA 11/2020 - 11/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 04/2002
5	Formaldehyde (Formol)FDA Link 11/2020 - 10/2005
4	Viral RNAIBA 01/2022 - 02/2015
4	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2014
4	InterferonsIBA 03/2021 - 12/2008
4	AntibodiesIBA 01/2021 - 05/2010
4	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2012
3	CholesterolIBA 03/2022 - 01/2010
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 11/2011
3	VimentinIBA 01/2022 - 12/2007
3	Viral AntigensIBA 12/2021 - 01/2013
3	VaccinesIBA 01/2021 - 01/2016
3	InterleukinsIBA 01/2018 - 08/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2015 - 04/2002
3	Tissue Inhibitor of Metalloproteinase-2IBA 04/2012 - 10/2009
3	beta-Galactosidase (Lactaid)IBA 10/2009 - 08/2005
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2008 - 04/2002
3	pentabromodiphenyl ether (PBDE)IBA 06/2007 - 06/2005
2	Viral ProteinsIBA 05/2022 - 09/2010
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2022 - 10/2015
2	SteroidsIBA 01/2022 - 01/2018
2	Interleukin-12 (IL 12)IBA 01/2022 - 12/2008
2	C-Type Lectins (C-Type Lectin)IBA 12/2021 - 01/2019
2	Tamoxifen FDA LinkGeneric 11/2021 - 08/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2013
2	IronIBA 11/2020 - 09/2018
2	Toll-Like Receptor 4IBA 01/2020 - 01/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2019 - 03/2012
2	Myelin Basic ProteinIBA 02/2019 - 01/2018
2	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 05/2016
2	Interferon-betaIBA 01/2018 - 12/2007
2	Interleukin-10 ReceptorsIBA 01/2018 - 01/2016
2	Interleukin-2 (IL2)IBA 01/2018 - 12/2008
2	Interferon Type IIBA 01/2018 - 09/2017
2	Interferon LambdaIBA 09/2017 - 10/2016
2	CollagenIBA 01/2016 - 03/2012
2	SilverIBA 01/2016 - 05/2010
2	Coloring Agents (Dyes)IBA 01/2016 - 05/2010
2	LipidsIBA 01/2016 - 01/2010
2	CopperIBA 07/2015 - 12/2007
2	Chelating AgentsIBA 07/2015 - 12/2007
2	Myelin-Oligodendrocyte GlycoproteinIBA 02/2015 - 01/2014
2	EnzymesIBA 02/2015 - 10/2009
2	TubulinIBA 01/2015 - 07/2012
2	Amyloid beta-PeptidesIBA 05/2010 - 06/2008
2	Monoclonal AntibodiesIBA 11/2008 - 11/2003
2	Transcription Factors (Transcription Factor)IBA 09/2007 - 08/2007
2	Interferon-gamma (Interferon, gamma)IBA 09/2007 - 08/2006
2	Polychlorinated Biphenyls (PCBs)IBA 06/2007 - 11/2006
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2022
1	vasostatinIBA 05/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2022
1	alpha-SynucleinIBA 05/2022
1	Oxygen (Dioxygen)IBA 03/2022

Therapy/Procedure

13	Therapeutics 05/2022 - 11/2003
5	Transplantation 05/2018 - 01/2012
2	Oncolytic Virotherapy 03/2021 - 01/2017
2	Cell Transplantation 01/2013 - 12/2007